Amedisys, Inc. (AMED)
USD 92.22
(0.42%)
USD 92.22
(0.42%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 940.38 Million USD | 8.13% |
| 2022 | 869.67 Million USD | -1.25% |
| 2021 | 880.64 Million USD | 16.42% |
| 2020 | 756.45 Million USD | 21.77% |
| 2019 | 621.23 Million USD | 164.93% |
| 2018 | 234.48 Million USD | -21.06% |
| 2017 | 297.05 Million USD | 8.86% |
| 2016 | 272.88 Million USD | -0.64% |
| 2015 | 274.64 Million USD | 0.98% |
| 2014 | 271.98 Million USD | -23.15% |
| 2013 | 353.92 Million USD | 28.07% |
| 2012 | 276.36 Million USD | -18.27% |
| 2011 | 338.13 Million USD | -19.51% |
| 2010 | 420.11 Million USD | -3.65% |
| 2009 | 436.01 Million USD | -14.18% |
| 2008 | 508.07 Million USD | 264.76% |
| 2007 | 139.29 Million USD | 39.64% |
| 2006 | 99.74 Million USD | -32.33% |
| 2005 | 147.39 Million USD | 187.55% |
| 2004 | 51.26 Million USD | 24.8% |
| 2003 | 41.07 Million USD | -0.69% |
| 2002 | 41.36 Million USD | -6.56% |
| 2001 | 44.26 Million USD | 1.78% |
| 2000 | 43.49 Million USD | -16.67% |
| 1999 | 52.18 Million USD | -6.82% |
| 1998 | 56 Million USD | 283.89% |
| 1997 | 14.59 Million USD | 18.08% |
| 1996 | 12.35 Million USD | 71.61% |
| 1995 | 7.2 Million USD | 75.61% |
| 1994 | 4.1 Million USD | 70.83% |
| 1993 | 2.4 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 938.48 Million USD | -0.92% |
| 2024 Q1 | 947.21 Million USD | 0.73% |
| 2023 Q1 | 813.61 Million USD | -6.45% |
| 2023 Q3 | 933.89 Million USD | 1.33% |
| 2023 Q2 | 921.64 Million USD | 13.28% |
| 2023 Q4 | 940.38 Million USD | 0.69% |
| 2023 FY | 940.38 Million USD | 8.13% |
| 2022 Q3 | 912.51 Million USD | -5.14% |
| 2022 FY | 869.67 Million USD | -1.25% |
| 2022 Q1 | 887.74 Million USD | 0.81% |
| 2022 Q2 | 961.99 Million USD | 8.36% |
| 2022 Q4 | 869.67 Million USD | -4.7% |
| 2021 Q2 | 723.67 Million USD | -7.65% |
| 2021 Q3 | 988.84 Million USD | 36.64% |
| 2021 FY | 880.64 Million USD | 16.42% |
| 2021 Q1 | 783.63 Million USD | 3.59% |
| 2021 Q4 | 880.64 Million USD | -10.94% |
| 2020 Q2 | 923.22 Million USD | 21.49% |
| 2020 Q4 | 756.45 Million USD | -10.48% |
| 2020 Q3 | 844.97 Million USD | -8.48% |
| 2020 Q1 | 759.94 Million USD | 22.33% |
| 2020 FY | 756.45 Million USD | 21.77% |
| 2019 Q1 | 663.03 Million USD | 182.76% |
| 2019 FY | 621.23 Million USD | 164.93% |
| 2019 Q4 | 621.23 Million USD | 2.02% |
| 2019 Q2 | 642.92 Million USD | -3.03% |
| 2019 Q3 | 608.91 Million USD | -5.29% |
| 2018 Q2 | 344.26 Million USD | 17.6% |
| 2018 Q3 | 280.39 Million USD | -18.55% |
| 2018 Q4 | 234.48 Million USD | -16.37% |
| 2018 Q1 | 292.73 Million USD | -1.46% |
| 2018 FY | 234.48 Million USD | -21.06% |
| 2017 Q2 | 312.81 Million USD | 14.3% |
| 2017 Q3 | 286.31 Million USD | -8.47% |
| 2017 Q4 | 297.05 Million USD | 3.75% |
| 2017 Q1 | 273.68 Million USD | 0.29% |
| 2017 FY | 297.05 Million USD | 8.86% |
| 2016 FY | 272.88 Million USD | -0.64% |
| 2016 Q3 | 275.35 Million USD | -2.8% |
| 2016 Q4 | 272.88 Million USD | -0.9% |
| 2016 Q1 | 294.86 Million USD | 7.36% |
| 2016 Q2 | 283.27 Million USD | -3.93% |
| 2015 Q2 | 265.38 Million USD | 3.71% |
| 2015 Q1 | 255.89 Million USD | -5.92% |
| 2015 FY | 274.64 Million USD | 0.98% |
| 2015 Q4 | 274.64 Million USD | 0.8% |
| 2015 Q3 | 272.46 Million USD | 2.67% |
| 2014 Q2 | 339.25 Million USD | -6.92% |
| 2014 Q4 | 271.98 Million USD | -9.07% |
| 2014 FY | 271.98 Million USD | -23.15% |
| 2014 Q1 | 364.47 Million USD | 2.98% |
| 2014 Q3 | 299.11 Million USD | -11.83% |
| 2013 Q3 | 376.77 Million USD | 60.18% |
| 2013 FY | 353.92 Million USD | 28.07% |
| 2013 Q2 | 235.22 Million USD | -6.11% |
| 2013 Q4 | 353.92 Million USD | -6.06% |
| 2013 Q1 | 250.53 Million USD | -9.35% |
| 2012 Q4 | 276.36 Million USD | -9.01% |
| 2012 Q1 | 325.4 Million USD | -3.77% |
| 2012 Q2 | 316.97 Million USD | -2.59% |
| 2012 Q3 | 303.74 Million USD | -4.18% |
| 2012 FY | 276.36 Million USD | -18.27% |
| 2011 Q1 | 423.43 Million USD | 0.79% |
| 2011 FY | 338.13 Million USD | -19.51% |
| 2011 Q2 | 410.66 Million USD | -3.01% |
| 2011 Q3 | 334.79 Million USD | -18.48% |
| 2011 Q4 | 338.13 Million USD | 1.0% |
| 2010 FY | 420.11 Million USD | -3.65% |
| 2010 Q1 | 438.03 Million USD | 0.46% |
| 2010 Q2 | 2.09 Billion USD | 378.68% |
| 2010 Q4 | 420.11 Million USD | 1.06% |
| 2010 Q3 | 415.7 Million USD | -80.17% |
| 2009 Q2 | 440.55 Million USD | -9.78% |
| 2009 Q4 | 436.01 Million USD | -1.97% |
| 2009 Q3 | 444.79 Million USD | 0.96% |
| 2009 Q1 | 488.29 Million USD | -3.89% |
| 2009 FY | 436.01 Million USD | -14.18% |
| 2008 FY | 508.07 Million USD | 264.76% |
| 2008 Q1 | 568.5 Million USD | 308.14% |
| 2008 Q2 | 525.68 Million USD | -7.53% |
| 2008 Q3 | 521.65 Million USD | -0.77% |
| 2008 Q4 | 508.07 Million USD | -2.6% |
| 2007 Q2 | 119.22 Million USD | 15.61% |
| 2007 FY | 139.29 Million USD | 39.64% |
| 2007 Q3 | 139.74 Million USD | 17.21% |
| 2007 Q1 | 103.13 Million USD | 3.39% |
| 2007 Q4 | 139.29 Million USD | -0.33% |
| 2006 Q1 | 136.57 Million USD | -7.34% |
| 2006 FY | 99.74 Million USD | -32.33% |
| 2006 Q2 | 131.82 Million USD | -3.48% |
| 2006 Q3 | 138.43 Million USD | 5.02% |
| 2006 Q4 | 99.74 Million USD | -27.94% |
| 2005 Q3 | 148.15 Million USD | 133.88% |
| 2005 FY | 147.39 Million USD | 187.55% |
| 2005 Q4 | 147.39 Million USD | -0.51% |
| 2005 Q2 | 63.34 Million USD | 7.5% |
| 2005 Q1 | 58.92 Million USD | 14.96% |
| 2004 Q1 | 48.54 Million USD | 18.2% |
| 2004 FY | 51.26 Million USD | 24.8% |
| 2004 Q4 | 51.26 Million USD | 9.24% |
| 2004 Q3 | 46.92 Million USD | 0.01% |
| 2004 Q2 | 46.91 Million USD | -3.36% |
| 2003 Q2 | 38.93 Million USD | 0.05% |
| 2003 Q1 | 38.9 Million USD | -5.93% |
| 2003 Q4 | 41.07 Million USD | -2.93% |
| 2003 FY | 41.07 Million USD | -0.69% |
| 2003 Q3 | 42.31 Million USD | 8.69% |
| 2002 Q4 | 41.36 Million USD | -4.57% |
| 2002 Q2 | 43.01 Million USD | 20.91% |
| 2002 Q1 | 35.57 Million USD | -19.64% |
| 2002 FY | 41.36 Million USD | -6.56% |
| 2002 Q3 | 43.34 Million USD | 0.77% |
| 2001 Q3 | 42.5 Million USD | 4.41% |
| 2001 FY | 44.26 Million USD | 1.78% |
| 2001 Q2 | 40.7 Million USD | -12.61% |
| 2001 Q1 | 46.58 Million USD | 7.11% |
| 2001 Q4 | 44.26 Million USD | 4.15% |
| 2000 FY | 43.49 Million USD | -16.67% |
| 2000 Q2 | 53.89 Million USD | 4.93% |
| 2000 Q4 | 43.49 Million USD | -17.28% |
| 2000 Q3 | 52.57 Million USD | -2.46% |
| 2000 Q1 | 51.36 Million USD | -6.26% |
| 1999 Q1 | 64.7 Million USD | 15.52% |
| 1999 Q4 | 54.8 Million USD | -7.12% |
| 1999 Q3 | 59 Million USD | -17.94% |
| 1999 FY | 52.18 Million USD | -6.82% |
| 1999 Q2 | 71.9 Million USD | 11.13% |
| 1998 FY | 56 Million USD | 283.89% |
| 1998 Q3 | 18.7 Million USD | -15.38% |
| 1998 Q4 | 56 Million USD | 199.51% |
| 1998 Q1 | 16 Million USD | 9.66% |
| 1998 Q2 | 22.1 Million USD | 38.13% |
| 1997 Q3 | 14.1 Million USD | 5.22% |
| 1997 Q2 | 13.4 Million USD | 1.52% |
| 1997 FY | 14.59 Million USD | 18.08% |
| 1997 Q1 | 13.2 Million USD | 6.83% |
| 1997 Q4 | 14.59 Million USD | 3.48% |
| 1996 Q2 | 9.9 Million USD | 17.86% |
| 1996 Q3 | 11.1 Million USD | 12.12% |
| 1996 FY | 12.35 Million USD | 71.61% |
| 1996 Q1 | 8.4 Million USD | 16.67% |
| 1996 Q4 | 12.35 Million USD | 11.31% |
| 1995 FY | 7.2 Million USD | 75.61% |
| 1995 Q2 | 6.4 Million USD | 45.45% |
| 1995 Q1 | 4.4 Million USD | 7.32% |
| 1995 Q3 | 5.9 Million USD | -7.81% |
| 1995 Q4 | 7.2 Million USD | 22.03% |
| 1994 FY | 4.1 Million USD | 70.83% |
| 1994 Q4 | 4.1 Million USD | 0.0% |
| 1994 Q2 | 3.3 Million USD | 6.45% |
| 1994 Q1 | 3.1 Million USD | 29.17% |
| 1993 FY | 2.4 Million USD | 0.0% |
| 1993 Q4 | 2.4 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 2.47 Billion USD | 61.946% |
| Addus HomeCare Corporation | 317.73 Million USD | -195.969% |
| AirSculpt Technologies, Inc. | 129.56 Million USD | -625.831% |
| American Oncology Network, Inc. | 368.72 Million USD | -155.037% |
| Astrana Health, Inc. | 522.59 Million USD | -79.946% |
| Aveanna Healthcare Holdings Inc. | 1.76 Billion USD | 46.708% |
| IMAC Holdings, Inc. | 1.89 Million USD | -49478.44% |
| biote Corp. | 191.84 Million USD | -390.191% |
| Cryo-Cell International, Inc. | 72.25 Million USD | -1201.538% |
| Cross Country Healthcare, Inc. | 205.92 Million USD | -356.667% |
| COMPASS Pathways plc | 50.24 Million USD | -1771.678% |
| DocGo Inc. | 185.28 Million USD | -407.546% |
| The Ensign Group, Inc. | 2.68 Billion USD | 64.914% |
| Healthcare Services Group, Inc. | 346.56 Million USD | -171.344% |
| InnovAge Holding Corp. | 247.85 Million USD | -279.413% |
| Assure Holdings Corp. | 22.84 Million USD | -4015.659% |
| The Joint Corp. | 62.37 Million USD | -1407.538% |
| LifeStance Health Group, Inc. | 804.27 Million USD | -16.923% |
| Mobile-health Network Solutions Class A Ordinary Shares | 3.81 Million USD | -24574.548% |
| ModivCare Inc. | 1.61 Billion USD | 41.63% |
| NewGenIvf Group Limited | 1.24 Million USD | -75649.999% |
| Novo Integrated Sciences, Inc. | 11.06 Million USD | -8399.542% |
| Option Care Health, Inc. | 1.9 Billion USD | 50.679% |
| P3 Health Partners Inc. | 427.3 Million USD | -120.074% |
| P3 Health Partners Inc. | 427.3 Million USD | -120.074% |
| The Pennant Group, Inc. | 394.17 Million USD | -138.57% |
| Surgery Partners, Inc. | 3.65 Billion USD | 74.287% |
| Syra Health Corp. Class A Common Stock | 910.07 Thousand USD | -103231.055% |
| Talkspace, Inc. | 23.57 Million USD | -3888.916% |
| Talkspace, Inc. | 23.57 Million USD | -3888.916% |
| The Oncology Institute, Inc. | 162.39 Million USD | -479.081% |
| The Oncology Institute, Inc. | 162.39 Million USD | -479.081% |